A Global Collaboration
The University of Washington, and collaborators at Rockefeller University (NYC), FIOCRUZ (Brazil), IRESSEF (Senegal), KRISP (South Africa), Aga Khan University (Pakistan) and Chang Gung University (Taiwan) were awarded a NIH National Institutes of Allergy and Infectious Disease (NIAID) Centers for Research in Emerging Infectious Diseases (CREID) grant for $8.75 M for 5 years to form the UNITED WORLD for ANTIVIRAL RESEARCH NETWORK (UWARN). The timing is critical, as UWARN will provide surveillance for emerging pandemic viruses, develop urgently needed diagnostics and therapeutics, and expand understanding of viral immune responses, which is key to vaccine development.
“We are very excited to establish UWARN, and the new collaborations with the five overseas partners to better address viral pandemics.” - Wes C. Van Voorhis, Co-Director of CERID
Wesley C. Van Voorhis Co-Director of the Center for Emerging and Reemerging Infectious Disease (CERID) brought together top investigators from the University of Washington, Fred Hutchinson Cancer Research Center, the Institute of Protein Design (IPD), the Rockefeller University and abroad to form the United World Antiviral Research Network (UWARN). Van Voorhis stated: “We are very excited to establish UWARN, and the new collaborations with the five overseas partners to better address viral pandemics.”